Investors will need to be brave to take advantage of the opportunities in Chinese equities.
Sentiment toward biotech companies may deteriorate again if efforts to develop treatments for Covid-19 prove to be unsuccessful, according to Polar Capital.
Envy Capital’s new CEO; Promotion at UBS; Polar buys value; Blackrock’s foundation for good; Naming financial roles; Event delays; Asset manager outlooks; Bart Simpson and more.
Over the last ten years, new technology funds surged ahead while “old economy” energy and mining funds struggled to stay even.
FSA compares the Henderson Horizon Global Technology Fund with the Polar Capital Global Technology Fund.